106 related articles for article (PubMed ID: 3481837)
1. [Transfer of ofloxacin into suction blister fluid after its oral administration].
Aoyama H; Sugiyama H; Ishii T; Kawauchi T; Kasuya T; Nishizaki A; Okuda J
Jpn J Antibiot; 1987 Nov; 40(11):1937-40. PubMed ID: 3481837
[TBL] [Abstract][Full Text] [Related]
2. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
[TBL] [Abstract][Full Text] [Related]
3. [Transfer of fosfomycin into human burn blister fluid and its pharmacokinetic analysis].
Koh B; Izawa Y; Sugiyama H; Aoyama H; Komiya I
Jpn J Antibiot; 1986 Nov; 39(11):2863-8. PubMed ID: 3820568
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin.
Schreiner A; Bergan T; Hellum KB; Digranes A
Rev Infect Dis; 1981; 3(1):125-31. PubMed ID: 7221355
[TBL] [Abstract][Full Text] [Related]
5. [Transfer of cefmenoxime to burn blister fluids].
Nishizaki A; Aoyama H; Koh T; Izawa Y
Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
[TBL] [Abstract][Full Text] [Related]
6. [Transfer of cefotetan into exudates from excoriated skin wounds].
Sugiyama H; Hatano T; Takayanagi K; Aoyama H; Kikuchi Y
Jpn J Antibiot; 1986 May; 39(5):1297-301. PubMed ID: 3463777
[TBL] [Abstract][Full Text] [Related]
7. [Transfer of latamoxef into human burn blister fluid and its pharmacokinetic analysis].
Aoyama H; Sugiyama H; Suzuki I; Nishizaki A; Izawa Y; Oguma T; Yamada H
Jpn J Antibiot; 1985 Oct; 38(10):2821-6. PubMed ID: 4078995
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.
Kalager T; Digranes A; Bergan T; Rolstad T
J Antimicrob Chemother; 1986 Jun; 17(6):795-800. PubMed ID: 3460984
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole concentrations in human skin blister fluid and plasma.
Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
[TBL] [Abstract][Full Text] [Related]
10. Penetration of Pazufloxacin into the Fluid of Suction Blisters Induced in Human Skin.
Totsuka K; Tei M; Kodama K; Yafune A
J Infect Chemother; 1996; 2(4):280-282. PubMed ID: 29681382
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of ofloxacin tablets in comparison to oral solution.
Malerczyk V; Verho M; Korn A; Rangoonwala R
Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and blister fluid penetration of brodimoprim in adults.
Novelli A; Mazzei T; Meli E; Cassetta MI; Fallani S; Periti P
J Chemother; 1993 Dec; 5(6):494-8. PubMed ID: 8195844
[TBL] [Abstract][Full Text] [Related]
13. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
[TBL] [Abstract][Full Text] [Related]
14. Penetration of antibiotics into human leukocytes and dermal suction blisters.
Solberg CO; Halstensen A; Digranes A; Hellum KB
Rev Infect Dis; 1983; 5 Suppl 3():S468-73. PubMed ID: 6635436
[TBL] [Abstract][Full Text] [Related]
15. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
Królicki A
Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.
Warlich R; Korting HC; Schäfer-Korting M; Mutschler E
Antimicrob Agents Chemother; 1990 Jan; 34(1):78-81. PubMed ID: 2327762
[TBL] [Abstract][Full Text] [Related]
17. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
[TBL] [Abstract][Full Text] [Related]
18. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
[TBL] [Abstract][Full Text] [Related]
19. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
[TBL] [Abstract][Full Text] [Related]
20. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.
Humbert P; Treffel P; Makki S; Millet J; Agache P
Arch Dermatol Res; 1991; 283(5):297-9. PubMed ID: 1929553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
